ArticleBrain pathology (Zurich, Switzerland)2018

Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.

Sam Loveless et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.